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Abstract: Introduction: The main purpose of emergency department (ED) managementfor renal colic is prompt pain
relief. The present study aimed to compare the analgesic effects of intravenus (IV) ketofol with morphine in
management of ketorolac persistent renal colic. Methods: This study is a single blind randomized, clinical trial,
on patients who were presented to ED with renal colic, whose pain was resistant to 30 mg IV ketorolac. The
patients were randomly assigned to either IV morphine (0.1 mg/kg) or IV ketofol (0.75 mg/kg propofol and 0.75
mg/kg) and the measures of treatment efficacy were compared between the groups after 5 and 10 minutes.
Results: 90 patients with mean age of 38.01±9.78 years were randomly divided into 2 groups of 45 (66.7% male).
Treatment failure rate was significantly lower in ketofol group after 5 (20% vs 62.2%, p < 0.001) and 10 minutes
(11.1% vs 44.4%, p < 0.001). ARR and NNT for ketofol after 5 miutes were 42.22% (95% CI: 23.86 - 60.59) and 3
(95% CI: 1.7 - 4.2), respectively. After 10 minutes, these measures reached 33.33 (95% CI:16.16 - 50.51) and 4 (95%
CI: 2.0 - 6.2), respectively. NNH and ARI for hallucination or agitation were 12 (95% CI: 5.8 - 174.2) and 8.89%
(0.57 - 17.20), respectively. Conclusion: The results of the present study, showed the significant superiority of
ketofol (NNT at 5 minute = 3 and NNT at 10 minute = 4) in ketorolac resistant renal colic pain management.
However, its NNH of 12, could limit its routine application in ED for this purpose.
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1. Introduction
R
enal colic usually presents as a severe and intermittent
flank pain that can radiate to the genitalia, abdomen
and groin (1, 2). It is a common cause for emergency
department (ED) visits and affects 3-5% of the general popu-
lation (3). Its incidence is higher in men and increases with
age (4). The main purpose of ED managament is prompt pain
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relief. Both non-steroidal anti-inflammatory drugs (NSAIDs)
and opioids are usually used in this regard (1). In a met-
analysis, NSAIDs were found to be as effective as analgesic
agents in treatment of acute renal colic (5). NSAIDs are cheap
and easily available but may cause complications such as
renal failure and gastrointestinal bleeding (6). Opioids are
highly potent drugs as well, but havethe risk of dependency
and respiratory depression and cause more adverse side ef-
fects compared to NSAIDs (7). In addition, the painwon’t
be relieved inup to 42% of renal colic patients treated with
morphineand 33% of those treated with ketorolac (8). Alter-
native choices such as ketofol (a combination of ketamine
and propofol) are available for this population (9). Ketamine
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is a phencyclidine derivative drug with analgesic, amnes-
tic and sedative effects without respiratory side effects (10,
11). In addition, ketamine has antidepressive and smooth
muscle relaxant effects that can facilitate stone passage (12).
Propofol is an alkylphenol derivative drug withsedative effect
(13). In ketofol, ketamine and propofol have a synergistic ef-
fect with fewer side effects compared to both ketamine and
propofol alone (9). Based on the above-mentioned points,
the present study was aimed to compare the analgesic effects
of ketofol withmorphine sulphate in management of ketoro-
lac resistant renal colics.
2. Methods
2.1. Study setting and design
This study is a randomized, controlled, single blind, paral-
lel, clinical trial, which was performed in the ED of Imam
Khomeini Hospital, Urmia, Iran between 23 July 2014 and 18
March 2015. The Ethics Committee of Urmia University Of
Medical Sciences approved the study on 20 May 2014 (ap-
proval number is umsu. rec. 1393.66). Written informed
consent was obtained from all participants. The study was
registered at Iranian registry of clinical trial (IRCT number:
IRCT2014052417812N1).
2.2. Participants
This study was conducted on patients whowere presented to
ED with chief complaint of flank pain and highly suspect-
edrenal colic. All patients, whose pain severity was greater
than 7 and did not respond to 30 mg intravenous (IV) ketoro-
lac, were includedusing convenience sampling. The exclu-
sion criteria were possible allergy to NSAIDs, opioids, propo-
fol, egg, and ketamine; addiction to opioid; renal failure; gas-
trointestinal bleeding and recent use of analgesics. Renal
colic was defined as acute severe flank pain that radiated to
ipsilateral groin. The intensity of pain was measured on a
100 millimeter (10 numerical) visual analogue scale (VAS). 10
was considered the worst possible pain and 0 was considered
painless.
2.3. Intervention
Patients were randomly divided into two groups using per-
mutated blocks of 4. Each block contained a pre-specified
number of treatment assignments in a random order. Alloca-
tion was planned before starting the study by one of the au-
thors. Participants and data analysts were blinded to treat-
ment allocation. We could not blind the researcher as a re-
sult of rapid sedative effects of ketofol. All renal colic pa-
tients received 30 mg IV ketorolac, and pain intensity was
measured before and 10 minutes after injection. If patients
pain score had not decreased by at least 3 scores after 10min-
utes, the second step was begun and the patient was enrolled
in the study. In group 1, (control group) patients were given
0.1 mg/kg IV morphine sulfate and in group 2 (intervention
group) patients were given IV ketofol (combination of 0.75
mg/kg propofol and 0.75 mg/kg ketamine) (14). The ketoro-
lac, morphine, ketamine, and propofol (PROVIVE) used, were
made by Alborz darou company of Iran, Darou pakhsh com-
pany of Iran, Hameln company of Germany and Claris com-
pany of India, respectively.
2.4. Outcome
Based on previous studies, 13mm reduction on VAS is clin-
ically significant; but in patients with severe pain, a greater
change on VAS is considered pain reduction (15-17). Thus,a
treatment leading to at least 3 scores reduction in pain inten-
sity was considered effective. If pain score had not dropped
by at least 30 mm after 10 minutes, pain management was
considered unsuccessful. The patients were under continu-
ousmonitoring of blood pressure, O2 saturation, and respira-
tory and heart rates. Respiratory depression, hallucination,
agitation, nausea, vomiting, and emergence phenomenon
were considered as secondary outcomes (complication).
2.5. Statistical analaysis
Considering 80% power, 95% confidence interval (CI), 1.7
variance of pain severity, and 0.8 minimum significant differ-
ence, sample size of 45 patients in each group was calculated
to be enough. Data were analyzed using SPSS 19. Quanti-
tative variables difference were assessed by Mann Whitney
U test, and qualitative and numerical variables difference
were assessed by Chi-square and Fishers exact tests. Num-
ber needed to treat (NNT), relative risk reduction (RRR), and
absulute risk reduction (ARR), as well asnumber needed to
harm (NNH) and absulute risk increase (ARI)were used as
measures of treatment efficacy. P< 0.05 was considered sta-
tistically significant.
3. Results
90 patients with mean age of 38.01±9.78 years (22-78) were
randomly divided into 2 groups of 45(66.7% male). Table
1 summarizes demographic data of the participants. Initial
pain score was 9.0 ± 1.2 in morphine and 9.2 ± 1.1 in keto-
fol groups (P = 0.469). Table 2 compares the characteris-
tics of pain management and complications betweenthe 2
groups.Treatment failure rate was significantly lower in keto-
fol group after 5 (20% vs 62.2%, p <0.001) and 10 minutes
(11.1% vs 44.4%, p < 0.001). ARR and NNT for ketofol after 5
miutes were 42.22% (95% CI: 23.86 - 60.59) and 3 (95% CI: 1.7
- 4.2), respectively. After 10 minutes, these measures reached
33.33 (95% CI:16.16 - 50.51) and 4 (95% CI: 2.0 - 6.2), respec-
tively. NNH and ARI for hallucination or agitation were 12
(95% CI: 5.8 - 174.2) and 8.89% (0.57 - 17.20), respectively.
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Table 1: Demoghraphic characteristics of the studied patients
Variables Morphine sulfate Ketofol P-Value
Sex; n (%)
Male 31 (68.9) 29 (64.4)
0.823
Female 14 (31.1) 16 (35.6)
Age mean ± SD (year) 39.29±12.40 36.73±6.05 0.217
Weight mean ± SD (Kg) 70.73±13.28 75.82±10.83 0.049
Stone size mean ± SD (mm) 6.38±1.85 6.04±1.76 0.383
SD: standard deviation.
Table 2: Comparision of treatment effects and cmplications between morphine and ketofol groups
Variables Morphine sulfate Ketofol P-Value
Pain Intensity mean± SD
On admission 9.00±1.22 9.18±1.09 0.469
5 minutes after administration 6.76±3.13 3.24±2.83 < 0.001
10 minutes after administration 4.96±3.83 2.40±2.77 <0.001
Failure rate; n (%)
5 minutes after administration 28 (62.2) 9 (20) < 0.001
10 minutes after administration 20 (44.4) 5 (11.1) < 0.001
Complication; n (%)
Hallucination, agitation 0 (0) 4 (8.9) < 0.058
Nausea, vomiting 2 (4.4) 0 (0) < 0.041
Stone size mean ± SD (mm) 6.38±1.85 6.04±1.76 0.383
SD: standard deviation.
4. Discussion
The results of the present study, showed the significant supe-
riority of ketofol (NNT at 5 minute = 3 and NNT at 10 minute
= 4) in rapid pain management of patients presented to ED
complaining from renal colic and resistant to ketorolac. NNT
of 3 means that about one in every 3 patients treated with
ketofol will benefit from the treatment after 5 minutes. How-
ever, its NNH was 12, which means that about one in every
12 patientstreated with ketofol will be affected with hallu-
cination andagitation. This relatively high NNH could limit
routine application of ketofol in this regard. We didn’t find
any studiesthatverified using ketofol for treating acute pain
of urolithiasisup to the time of writing this article. Thus, this
study is the first to verify the effect of ketofol, and compare
IV ketofol with IV morphine for treating acute renal colic. Re-
garding the opioid agents for treating acute renal colic, the
result of our study is similar to those previously published
(1, 18-23). Holdgate and Pollock, performed a systematic re-
view on efficacy of NSAIDs and opioids. They reported that
patients who received opioids, neededa rescue dose of anal-
gesicsmore frequently (1). Safdar et al. investigated the effect
of ketorolac and morphine for treating renal colic. They re-
portedthat 30% of the patients who received a combination
of ketorolac and morphine needed a rescue dose (8). Ma-
soumi et al. compared IV acetaminophen with morphine
for treating renal colic and concluded that acetaminophen
is more effective than morphine (24). In contrast, azizkhani
et al. reported that morphine is more effective than ac-
etaminophen for this purpose (25). However, both groups
reported that morphine had more side effects (24, 25). In ad-
dition, Soleimanpour et al. compared IV lidocaine and mor-
phie, and showed that lidocaine is siginificantly more effec-
tive in relieving pain in renal colic patients (26). Yet, Bektas
et al. revealed that paracetamol and morphine are equally
effective for this purpose (27). Researchers have been trying
to verify an alternative drug for treating acute renal colic in
emergency settings (28). Ketofol has been used in anesthesi-
ology and has recently begun to spread into ED (29). Nejati
et al. compared ketamine/propofol and midazolam/fentanyl
in the ED and found that ketamine/propofol is safe and ef-
fective for sedation and analgesia (14). Willman et al. eval-
uated the effectiveness of ketofol for orthopedic procedural
sedation in ED. They concluded that ketofol is an effective
drug with minimal and transient side effects (9). The present
study illustrated that efficacy of ketofol in renal colic pain re-
lief is more than morphine. However, further study is needed
before we suggestroutine use of ketofol, in this regard.
4.1. Limitations
Due to sedative effect of ketofol, we could only blind the pa-
tients and not the researchers, thus this study issingle blind.
This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0).
Downloaded from: www.jemerg.com
205 Emergency. 2016; 4 (4): 205-206
Conveniences amplingand short duration of follow-up are
also among the most important limitations of the present
trial.
5. Conclusion
The results of the present study, showed the significant supe-
riority of ketofol (NNT at 5 minute = 3 and NNT at 10 minute =
4) in ketorolac resistant renal colic pain management. How-
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